Management of floating thrombus in the aortic arch

J Thorac Cardiovasc Surg. 2016 Sep;152(3):810-7. doi: 10.1016/j.jtcvs.2016.03.078. Epub 2016 Apr 13.

Abstract

Objective: Floating aortic thrombus is an underrecognized source of systemic emboli and carries a life-threatening risk of stroke when located in the aortic arch. Optimal treatment is not established in available guidelines. We report our experience in managing floating thrombi in the aortic arch.

Methods: Consecutive patients diagnosed with a floating aortic arch thrombus at a tertiary referral center between January 2008 and December 2014 were reviewed. Perioperative and midterm outcomes were assessed.

Results: Ten patients (8 female) with a median age of 56 years (range, 47-82 years) were identified. Eight patients presented with a symptomatic embolic event, and 2 patients were asymptomatic. One patient presenting with stroke due to embolic occlusion of all supra-aortic vessels died 2 days after admission. Three patients (2 asymptomatic and 1 unfit for surgery) were treated conservatively by anticoagulation, leading to thrombus resolution in 2 patients. In the third patient, the thrombus persisted despite anticoagulation, resulting in recurrent embolic events. The remaining 6 patients underwent open thrombectomy of the aortic arch during deep hypothermic circulatory arrest. All patients treated by surgery had an uneventful postoperative course with no recurrent thrombus or embolic event during follow-up. Median follow-up of all patients was 17 months (range, 11-89 months).

Conclusions: Floating aortic arch thrombus is a dangerous source of systemic emboli. Surgical removal of the thrombus is easy to perform and followed by good clinical results. Conservative treatment with anticoagulation may be considered in asymptomatic, inoperable or high-risk patients.

Keywords: aortic arch; embolism; thrombus.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / therapeutic use
  • Aorta, Thoracic*
  • Aortic Diseases / diagnostic imaging
  • Aortic Diseases / therapy*
  • Echocardiography, Transesophageal
  • Female
  • Humans
  • Male
  • Middle Aged
  • Recurrence
  • Risk Factors
  • Thrombectomy
  • Thrombosis / diagnostic imaging
  • Thrombosis / therapy*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anticoagulants